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Neutrophils are potent effector cells and contain a battery of harmful substances and
degrading enzymes. A silent neutrophil death, i.e., apoptosis, is therefore of importance
to avoid damage to the surrounding tissue and to enable termination of the acute
inflammatory process. There is a pile of evidence supporting the role for pro-inflammatory
cytokines in extending the life-span of neutrophils, but relatively few studies have
been devoted to mechanisms actively driving apoptosis induction in neutrophils. We
have previously demonstrated that natural killer (NK) cells can promote apoptosis in
healthy neutrophils. In this study, we set out to investigate how neutrophil sensitivity
to NK cell-mediated cytotoxicity is regulated under inflammatory conditions. Using
in vitro-activated neutrophils and a human skin chamber model that allowed collection
of in vivo-transmigrated neutrophils, we performed a comprehensive characterization
of neutrophil expression of ligands to NK cell receptors. These studies revealed a
dramatic downregulation of HLA class I molecules in inflammatory neutrophils, which was
associated with an enhanced susceptibility to NK cell cytotoxicity. Collectively, our data
shed light on the complex regulation of interactions between NK cells and neutrophils
during an inflammatory response and provide further support for a role of NK cells in the
resolution phase of inflammation.
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INTRODUCTION
Neutrophils are innate immune cells that play a key role in the defense against invading microbes.
In circulation, neutrophils are in a resting state, but in response to proinflammatory signals they
become alerted, extravasate andmigrate toward the site of damage or infection. Neutrophils contain
numerous intracellular granules containing pre-formed proteins needed to execute their functions.
Thus, when neutrophils are stimulated, they rapidly mobilize specific types of granules to equip
the cell with new surface structures and to release soluble factors to the extracellular space (1).
The transmigration process per se is dependent on degranulation, which enables attachment to
endothelial cells, and subsequently chemotaxis-driven migration (2). However, the rearrangement
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of surface structures does not only involve granule mobilization,
but also cleavage or internalization of surface structures; CD62L,
involved in attachment to endothelial cells, is for example shed
from the neutrophil surface already in circulation (3).
Neutrophils have a rich arsenal of toxic substances and
degrading enzymes stored in their granules, which are used to
eradicate an ingested prey. The toxic content makes neutrophils
a potential danger to the surrounding tissue and it is thus of
importance that neutrophils are removed from the inflammatory
site after they have fulfilled their tasks. A tightly controlled death
process where the cell is degraded from the inside while the
surface membrane remains intact, is therefore of importance
for termination of the inflammatory process (4). Neutrophil
apoptosis can be induced by interaction with other immune
cells inducing pro-apoptotic signaling via death receptors on
the neutrophil surface (5); e.g., we have previously reported
that interaction between NK cells and neutrophils can promote
neutrophil apoptosis (6).
Natural killer (NK) cells are cytotoxic cells that can kill
aberrant cells without prior sensitization (7). Besides their
undisputed role in the defense against viral infections and certain
malignancies, a growing body of evidence points to a role for NK
cells in immune regulation, both as an early source of cytokines
but also by selective killing of immune cells (6, 8–13). The
result of an encounter between an NK cell and a target cell
is determined by the balance between signals originating from
inhibitory and activating receptors expressed on the NK cell
surface; thus, the presence of cognate ligands to NK cell receptors
(NKRs) on the potential target cell determines the outcome of an
NK cell—target cell interaction. When the inhibitory signaling
is decreased, or the activating signaling increased, the NK cell
cytotoxic machinery may be activated, resulting in release of
cytotoxic granules into the immunological synapse. Among the
major activating receptors are the natural-killer group 2, member
D (NKG2D), recognizing MICA andMICB and different ULBPs;
DNAX accessory molecule-1 (DNAM-1), recognizing polio virus
receptor (PVR) and Nectin-2; 2B4 recognizing CD48; and the
group of natural cytotoxicity receptors (NCRs; NKp30, NKp44,
and NKp46), which in part constitute orphan receptors (14, 15),
while NKp30 recognizes B7-H6 and BAG-6 (16, 17). The main
inhibitory receptors are the inhibitory killer immunoglobulin-
like receptors (iKIRs) and NKG2A/CD94 that bind to specific
human leukocyte antigen (HLA) class I molecules on target
cells. HLA-C binds to the KIR2DL receptors, while certain
HLA-B and HLA-A molecules contain a Bw4 motif that
is recognized by KIR3DL1. The NKG2A/CD94 heterodimer
binds to the non-classical HLA-E molecule, which selectively
presents the leader peptides of classical HLA molecules and
thus reflects the overall expression of HLA class I in a cell.
In addition, the inhibitory receptor LILRB1 recognizes HLA
class I molecules. Moreover, HLA class I molecules may also
bind to activating NK cell receptors, where the NKG2C/CD94
heterodimer binds to HLA-E, and activating KIRs recognize
certain motifs on classical HLA class I molecules. The HLA
class I molecules can be up- or downregulated from the cell
surface in response to cellular signaling, and free soluble HLA
class I molecules has been described in serum, either secreted
from cells or shed from the cell surfaces due to proteolytic
cleavage (18–20).
As mentioned above, NK cells have been ascribed
immunomodulatory functions (21, 22) and previous work
from our group has demonstrated that NK cells induce apoptosis
in healthy neutrophils in an NCR- and Fas-dependent manner
(6). Moreover, in a human in vivo blister model of sterile
inflammation, NK cell entry into blisters coincided with
the appearance of apoptotic neutrophils, suggesting a role
for NK cells in terminating an inflammatory response (6).
With this background, we hypothesized that modulation of
neutrophil surface expression of NKR ligands upon neutrophil
activation may lead to altered sensitivity to NK cell-induced
apoptosis. In this study, we demonstrate that inflammatory
neutrophils, both in vitro-stimulated blood neutrophils
and in vivo-transmigrated neutrophils collected from skin
chamber exudates, are more susceptible to NK cell-mediated
apoptosis, and that the enhanced sensitivity is associated
with a pronounced downregulation of neutrophil HLA class
I expression.
RESULTS
Surface Expression of HLA Class I
Molecules Is Decreased Upon Neutrophil
Activation
NK cell cytotoxicity is triggered when the signals from activating
receptor-ligand interactions overcome the inhibitory signals
from inhibitory receptors. Thus, in a first set of experiments
we investigated to what extent activated neutrophils modulate
their expression of ligands to NKRs. In in vitro experiments,
we combined GM-CSF with the TLR7/8 agonist CL097 (23,
24) to activate freshly isolated neutrophils and screened the
neutrophil expression of ligands to activating and inhibiting
NKRs using flow cytometry. As demonstrated in Figure 1A,
neutrophils stimulated with CL097 and GM-CSF for 20min
at 37◦C displayed strong up-regulation of CD11b and CD66,
both classical markers for neutrophil activation, as well as loss
of CD62L. In parallel, we observed a significant decrease of
classical HLA class I molecules after 20min stimulation at
37◦C (HLA-ABC; Figure 1A). These results were confirmed with
two additional clones recognizing HLA-ABC (G46-2.6 and A6-
136; data not shown). Notably, a significant downregulation
of HLA class I was seen also without addition of stimuli
(Figure 1A). Furthermore, we observed decreased expression of
the DNAM-1 ligand PVR, and increased expression of MICA/B
and ULBP-3, both ligands to NKG2D, on the neutrophil surface
after 20min of stimulation with CL097/GM-CSF (Figure 1B),
while no robust changes were observed regarding expression
levels of Nectin-2, ULBP-1, ULBP-2/5/6, B7-H6, or NKp46-
ligand, all ligands to activating NKRs (Supplemental Figure 1).
Surface expression of CD48, a ligand to 2B4, could not
be detected on neither resting nor activated neutrophils
(data not shown). Extended GM-CSF and TLR stimulation
further decreased neutrophil surface expression of classical
HLA class I molecules, while expression levels of ligands
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FIGURE 1 | NKR ligand expression on in vitro-activated neutrophils. (A) Surface expression of HLA-ABC, CD11b, CD66 or CD62L as indicated, on resting neutrophils
kept on ice (ctrl) or in vitro-activated neutrophils stimulated for 20min at 37◦C alone or in presence of the TLR-agonist CL097 and GM-CSF (one-way ANOVA followed
by Dunnett’s multiple comparisons test). (B) Surface expression of indicated ligands to NKRs on resting neutrophils (ctrl) or in vitro-activated neutrophils stimulated for
20min at 37◦C with CL097/GM-CSF (paired t-test). (C) Expression of NKR ligands and neutrophil degranulation markers on resting neutrophils (ctrl) or in
vitro-activated neutrophils stimulated for 1, 2, or 4 h at 37◦C with CL097/GM-CSF (one-way ANOVA followed by Dunnett’s multiple comparisons test). Error bars
represent SEM.
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FIGURE 2 | Surface expression of ligands to inhibitory and activating NKRs on transmigrated neutrophils. Surface staining of indicated ligands to NKRs on
transmigrated neutrophils (ePMN), collected from exudates in the skin chamber model, and autologous blood neutrophils (bPMN). Paired t-test, error bars
represent SEM.
to activating NKRs displayed varying patterns (Figure 1C,
Supplemental Figure 1).
To investigate whether our observations in neutrophils
activated in vitro were consistent with expression patterns on
activated, extravasated neutrophils in vivo, we made use of
a human in vivo model where transmigrated neutrophils are
harvested from a serum-filled skin chamber placed on exposed
dermis (25). Transmigrated neutrophils were highly activated
as reflected by an increased CD11b expression and loss of
CD62L compared to resting autologous neutrophils harvested
from blood (Figure 2 and data not shown). Similar to the in
vitro-activated neutrophils, transmigrated neutrophils displayed
significantly decreased surface expression of classical HLA class
I molecules. Consistent with our data from in vitro-stimulated
neutrophils, transmigrated neutrophils did not display altered
surface expression of Nectin-2 and B7-H6. However, in contrast
to in vitro-stimulated neutrophils, transmigrated neutrophils did
not display decreased expression of PVR.
Downmodulation of NK Cell-Regulatory
HLA Molecules on Activated Neutrophils
HLA class I expression on hematopoietic cells is dominated by
HLA-A and -B, which are approximately 15 timesmore abundant
than HLA-C (26), which in turn is more abundant than the non-
classical HLA class I molecule, HLA-E. Given the important role
for HLA-C and HLA-E in regulation of NK cell effector functions
(27), we next investigated to what extent these HLA molecules
were also downregulated in response to neutrophil stimulation.
As shown in Figures 3A,B, we observed a strong downregulation
of both HLA-C and HLA-E already after 20min of stimulation.
The decreased HLA-C expression was observed also after longer
neutrophil stimulation (Figures 3C,D; Supplemental Figure 2).
Consistently, we observed a similar picture on transmigrated
neutrophils in vivo (Figures 3E,F).
In an attempt to understand the mechanism of HLA
downmodulation, we investigated whether HLA was internalized
upon neutrophil activation. Neutrophils were stained with a
FITC-conjugated anti-HLA-ABC antibody prior to stimulation.
After 20min CL097/GM-CSF stimulation, an anti-FITC mAb
was added, quenching the extracellular FITC signal. However,
as shown in Figure 4, the fluorescence detected from activated
neutrophils was quenched to a similar extent as resting
neutrophils, suggesting that internalization of HLA is not the
main explanation to the HLA downregulation observed on
activated neutrophils. Activated neutrophils release granules
containing various proteolytic enzymes, such as serine proteases,
e.g., elastase, proteinase 3, cathepsin G, and different matrix
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FIGURE 3 | Downmodulation of HLA-C and HLA-E on activated neutrophils. (A–D) Neutrophil staining of indicated HLA class I cell surface structures (HLA-C or
HLA-E) binding to inhibitory NKRs. Resting neutrophils were kept on ice (ctrl) or stimulated for 20min with the TLR-agonist CL097 and GM-CSF at 37◦C (A; paired
t-test) or for 1, 2, or 4 h under the same conditions (D; one-way ANOVA followed by Dunnett’s multiple comparisons test). (B) Representative staining of HLA-C and
HLA-E of resting neutrophils (gray) or neutrophils that had been stimulated with CL097/GM-CSF for 20min (orange). (C) Representative staining from one experiment
showing expression of HLA-C on resting neutrophils (gray) or neutrophils that had been stimulated with CL097/GM-CSF for 1 h (red). (E) Neutrophil staining of
indicated HLA class I molecules on transmigrated neutrophils from skin chamber exudates (ePMN) or resting autologous neutrophils (bPMN; paired t-test). (F)
Representative staining from one experiment showing the expression of HLA-C on resting neutrophils (gray) or transmigrated neutrophils (green). Error bars
represent SEM.
metalloproteases, and we next addressed to what extent
inhibition of specific enzymes could restore HLA expression
in activated neutrophils. However, Batimastat, an inhibitor of
matrix metalloproteases, did not affect the neutrophil surface
expression of HLA class I and neither did α1-antitrypsin nor
specific inhibitors of cathepsin G and PR3 (data not shown).
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FIGURE 4 | Decrease of surface HLA class I molecules is not explained by
internalization. Graph shows resting neutrophils stained with FITC-conjugated
HLA-ABC antibody prior to addition of buffer (ctrl) or CL097/GM-CSF for
20min at 37◦C, after which FITC-quenching antibody was added.
Reduced HLA Class I Expression on
Activated Neutrophils Translates Into
Enhanced Sensitivy to NK Cell Cytotoxicity
As activated neutrophils displayed lower expression of ligands
to inhibitory NKRs, and no or modest modulation of their
expression of ligands to activating NKRs was detected, we
speculated that the outcome of interactions between NK
cells and activated vs. resting neutrophils would differ. To
investigate the neutrophil sensitivity to NK cell cytotoxicity,
the viability of resting or pre-activated neutrophils was
determined after co-culture with pre-activated NK cells.
As demonstrated in Figures 5A,B, both transmigrated skin
chamber neutrophils and in vitro-stimulated neutrophils were
more sensitive to NK cell cytotoxicity compared to resting
neutrophils, as reflected by increased binding of Annexin V
to extracellular phosphatidyl serine and nuclear staining of
cells with compromised plasma membrane integrity with To-
Pro-3 (Figure 5C). Notably, addition of an HLA antibody,
blocking the inhibitory interaction between HLA and KIRs
or NKG2A/CD94, resulted in a significantly higher NK cell
cytotoxicity against resting neutrophils (Figure 5A). By contrast,
the cytotoxicity against activated neutrophils, which display low
expression of HLA class I molecules, did not further increase
upon HLA class I blockade. Blocking of NCR signaling via
NKp46 resulted in decreased NK cell-mediated killing of in vitro-
activated neutrophils (Supplemental Figure 3), consistent with
our previous findings for resting neutrophils (6).
DISCUSSION
After executing their tasks in peripheral tissues, neutrophils, with
their cargo of toxins and degrading enzymes, must undergo
apoptosis to prevent prolonged inflammation and resulting tissue
damage. During the last decade, a growing pile of evidence
has identified an important role for NK cells as modulators
of the immune response (21, 22, 24) and we have earlier
demonstrated that NK cells can induce apoptosis in neutrophils
in an NKp46-dependent manner (6). The outcome of NK cell—
target cell interactions is dependent not only on cell signaling
via activating receptors, but also on signaling via inhibitory
receptors. In this study we investigated the neutrophil surface
expression of ligands to inhibitory, as well as activating NKRs,
on both in vitro-activated neutrophils and in vivo-transmigrated
neutrophils isolated using a skin chamber model (25). With the
exception of certain NKG2D ligands, the expression of ligands
to activating NKRs remained largely unchanged upon neutrophil
activation. By contrast, we observed a substantial downregulation
of HLA class I molecules on activated neutrophils, which
included also less abundantHLA structures of importance for NK
cell regulation, HLA-C, and HLA-E.
HLA downregulation is a commonly used immunoevasive
strategy among virus-infected cells or tumor cells to avoid
T cell recognition and elimination. However, the decreased
HLA expression will reduce inhibitory signaling in NK cells
and thus allow missing-self recognition by NK cells (27–
29). The dramatic downregulation of HLA class I molecules
observed in this study necessarily involves downregulation of
the abundant HLA subtypes, HLA-A and -B which according
to previous reports comprise 95% of total HLA class I (26).
Interestingly, our analysis demonstrated that the downregulation
of HLA class I on activated neutrophils was not confined to
the most abundant HLA class I molecules but also included
pronounced downregulation of HLA-C and HLA-E. As HLA
class I molecules act as ligands to inhibitory NK cell receptors,
we hypothesized that the reduced surface expression of NK cell-
specific HLA-C and HLA-E would result in higher sensitivity to
NK cell cytotoxicity in inflammatory neutrophils. Indeed, the
loss of surface HLA class I molecules rendered inflammatory
neutrophils more susceptible to NK cell-mediated killing.
Our data suggest that HLA downregulation on inflammatory
neutrophils may serve the purpose to increase their susceptibility
to NK cell cytotoxicity and thus contribute to resolution of
the inflammatory process by NK-induced neutrophil apoptosis.
Chronic inflammatory diseases, such as rheumatoid arthritis,
are characterized by an ongoing inflammation and presence
of high numbers of inflammatory neutrophils (30). A focus
of further studies should be to what extent aberrant HLA
expression patterns or absence of certain NK cell phenotypes
may be related to disease grade and characteristics. In this
regard, it has been reported that the immature, less cytotoxic
CD56bright NK cells predominate in the inflamed synovium
(31). This finding is in line with our data, as the less
cytotoxic CD56bright NK cell population may rather fuel the
inflammatory process by producing inflammatory cytokines than
kill inflammatory neutrophils.
We were not able to pinpoint the exact mechanism for
neutrophil HLA downregulation in this study. It is possible that
HLA molecules are internalized upon neutrophil activation. To
test this hypothesis, we made use of an anti-FITC antibody,
which quenches the FITC. As the neutrophils were stained
with FITC-conjugated anti-HLA-ABC antibody before priming,
internalization would mean that also the FITC-conjugate
was internalized. The quenching antibody can only bind to
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FIGURE 5 | Activated neutrophils are more sensitive to NK cell cytotoxicity compared to resting neutrophils. (A) Percentage of dead neutrophils (PMN) after a 3 h
co-culture of neutrophils [pre-stimulated in vitro with CL097 and GM-CSF, or kept on ice (ctrl)] and bulk-NK cells at an E:T ratio of 10:1, with addition of an HLA
antibody as indicated (n = 7; one-way ANOVA followed by Dunnett’s multiple comparisons test). (B) Graph shows percentage of dead neutrophils after a 4 h
cytotoxicity assay performed using autologous NK effector cells toward transmigrated (ePMN) or blood neutrophils (bPMN; E:T ratio 10:1; n = 5; one-way ANOVA
followed by Dunnett’s multiple comparisons test). Error bars represent SEM. (C) Representative FACS plots showing percentage of dead neutrophils (transmigrated or
resting) measured using AnnexinV and To-Pro-3, after a 4 h co-culture with autologous NK cells.
extracellular FITC, and thus, any internal FITC signal would still
fluoresce when hit by light in the right wave length. However,
the FITC signal was not higher in activated neutrophils than
in resting neutrophils, and we could thus not conclude that
HLA was internalized. Alternatively, HLA molecules could be
shed from the cell surface. Neutrophil granules contain enzymes,
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such as the serine proteases, neutrophil elastase, cathepsin G,
and proteinase 3, which may be released upon neutrophil
transmigration to an inflammatory site (32, 33). Shedding of
surface B7-H6 from tumor cells has previously been described
as a cause of matrix metalloprotease-mediated shedding (34),
and presence of a soluble form of B7-H6 has been reported
in supernatants from in vitro-stimulated neutrophils (35). This
suggests that also neutrophil modulation of HLA molecules
may involve proteolytic shedding. Supporting this hypothesis,
the metalloprotease inhibitor Batimastat has been reported to
inhibit release of soluble HLA class I in activated lymphocytes
(19). In this study, however, we were unable to inhibit HLA
class I downregulation on neutrophils with Batimastat, although
the Batimastat readily inhibited shedding of CD62L from the
activated neutrophils. Notably, a fraction of serine proteases
from azurophil granules remain associated with the neutrophil
cell membrane after granule-mobilization (33), and there are
reports suggesting thatmembrane-bound forms of these enzymes
are relatively insensitive to protease inhibitors (36). Thus,
the inability of protease inhibitors to prevent HLA class I
downregulation does not preclude a role for these proteases in
this process.
A third alternative for the observed downregulation of HLA
expression could be that neutrophil activation leads to a change
in the HLA conformation, disabling antibody recognition of
HLA. Several studies have reported open conformers of HLA,
with the conformation change leading to a shift in receptor—
ligand interactions (37–39). Surface staining of resting and
activated neutrophils using an antibody recognizing an open
conformation of HLA class I did not reveal any increase in
HLA class I open conformers on activated neutrophils (data
not shown). Nevertheless, in the study we observed HLA class
I downregulation on activated neutrophils using five different
antibody clones detecting HLA molecules (clones G46-2.6,
W6/32 and A6-136 against HLA-ABC, clone DT9 against HLA-
C, and clone 3D12 against HLA-E) strongly suggesting that HLA
class I is decreased on the surface of inflammatory neutrophils.
In conclusion, we have demonstrated that both in vitro-
activated and in vivo-transmigrated neutrophils display
decreased surface expression of HLA class I molecules. In line
with the decreased HLA class I expression, inflammatory
neutrophils were more sensitive to NK cell-mediated
cytotoxicity, as the loss of inhibitory signaling tips the balance
toward NK cell activation and cytotoxicity. Collectively, our
study demonstrates that neutrophils dynamically modulate
their expression and release of NK cell receptor ligands, and
that NK cells may contribute to a controlled resolution of the
inflammatory process by killing activated neutrophils.
MATERIALS AND METHODS
Antibodies and Reagents
Following mAbs were used for detection of surface markers: anti-
CD11b APC (clone: ICRF44), CD48 BV421 (TÜ145), HLA-ABC
FITC (G46-2.6), CD62L APC (DREG-56), CD66 PE (B1.1; all
fromBDBiosciences, CA, USA), HLA-C (DT9,MerckMillipore),
HLA-ABC Alexa Fluor 647 (W6/32) and HLA-E PE-Cy7 (3D12;
both from Biolegend), B7-H6 (875002), ULBP1 PerCP (170818),
ULBP-3 PE (166510), ULBP-2/5/6 APC (165903; all from R&D
Systems, MN, USA), CD56 PE-Cy7 (N901, Beckman Coulter, IN,
USA), MICA/B viobright FITC (6D4, Miltenyi Biotech, Bergisch
Gladbach, Germany), and Alexa Fluor 488-conjugated goat anti-
mouse IgG (Invitrogen, CA, USA). Anti-B7-H6 (17B1.3) was
kindly provided by Prof E Vivier (CMIL, Marseille, France), and
anti-PVR (CD155; M5A10) and Nectin-2 (CD112; L14) were
received from the lab of Prof. A Moretta (Genova, Italy). Goat
serum and α1-antitrypsin were obtained from Sigma-Aldrich
(MO, USA), CL097 from InvivoGen (San Diego, CA), GM-CSF
from R&D Systems (MN, USA), anti-PR3 from Abcam (UK),
and Batimastat and cathepsin G inhibitor from Calbiochem
(CA, USA). In experiments where the extracellular FITC signal
was quenched, a Fluorescin/Oregon green polyclonal antibody
(ThermoFisher, Sweden) was used.
Isolation of Human Leukocytes
Buffy coats or fresh blood obtained from healthy donors were
mixed 1:1 with 2% dextran. After sedimentation of erythrocytes,
granulocytes and PBMCs were separated by density gradient
centrifugation (40, 41). Remaining erythrocytes were lysed in
distilled water to obtain a pure granulocyte population. This
method provides a granulocyte population of >95% purity. NK
cells were isolated from PBMCs using an NK cell isolation kit
(Miltenyi Biotec, Bergisch Gladbach, Germany), according to
the manufacturer’s protocol. To obtain activated, polyclonally
expanded NK cells (bulk), freshly isolated NK cells were
cultured on irradiated feeder cells in the presence of 100 U/mL
recombinant human IL-2 (Proleukin; Chiron) and 1.5 ng/ml
phytohemagglutinin (PHA) (GIBCO Ltd.).
Isolation of Transmigrated Neutrophils
In order to isolate in vivo-transmigrated neutrophils, a skin
chamber technique was used, described in detail elsewhere
(25, 42). In short, blisters were introduced on the forearm
on healthy volunteers using negative pressure. After 2 h, the
blister roofs were removed and collection chambers were placed
on top of the lesions. Autologous serum was added to the
chamber wells. After 24 h, the chambers were removed and
in vivo-transmigrated neutrophils were harvested from the skin
chamber fluid, with a granulocyte purity >90%, and with
mainly viable neutrophils (42). Autologous blood neutrophils
were isolated from peripheral blood as described above and
used as control cells. All neutrophils were diluted in Krebs
Ringer Glucose (KRG) supplemented with Ca2+, and stored on
melting ice until use. The study was approved by the regional
ethical board in Gothenburg (543-07) and voluntary donors gave
written informed consent in accordance with the declaration
of Helsinki.
Generation of Fusion Proteins for
Detection of NKp46 Ligand
HEK293T cells, transfected with a construct encoding for a fusion
protein consisting of the extracellular part of NKp46 fused to
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an Fc-portion of human IgG, were kindly provided by Prof.
O Mandelboim (Jerusalem, Israel). Details of the transfection
procedure has been described elsewhere (43, 44). Cells were
cultured in DMEM (Sigma-Aldrich) supplemented with 10%
heat inactivated fetal calf serum (FCS), 1% PEST, 1% L-glutamine
and Puromycin dihydrochloride (5µg/ml; Sigma-Aldrich). Cell
cultures were kept at 37◦C in a humidified, 5% CO2 atmosphere.
When reaching 70% confluency, medium was exchanged to low
protein medium supplemented with non-essential amino acids,
1% Penicillin-Streptomycin, 1% L-glutamine and 1% Sodium
Pyruvate. After 3 days, the cell-free supernatant was collected
and fusion proteins were purified with affinity chromatography
using a HiTrap Protein G column (GE Healthcare). Proteins
were eluted with 0.1M Glycine/HCl (pH 2,7-3), neutralized in
1M TRIS/HCl (pH 8), concentrated using an Amicon Ultra 15
centrifugation tube (Millipore) and stored in buffered NaCl in
−20◦C until use.
Expression of Surface Ligands on
Neutrophils
Freshly isolated neutrophils were stimulated with CL097/GM-
CSF (1µg/ml and 100 U/ml, respectively), at 37◦C for indicated
time. In some experiments, the matrix metalloproteinase
(MMP) inhibitor Batimastat (10µM), α1-antitrypsin (1µg/ml),
cathepsin G inhibitor (1µM) or anti-PR3 antibody (100 ng/ml)
were added to the cells. Supernatants were collected after priming
for detection of soluble HLA. Cells were stained with antibodies
for 30min at 4◦C. Degranulation/activation was monitored using
antibodies directed against the surface markers CD11b, CD62L,
and CD66. For detection of unconjugated antibodies (HLA-
C, B7-H6, PVR and Nectin-2), cells were saturated in 20%
goat serum for 10min prior to incubation with Alexa Fluor-
488 conjugated goat anti-mouse IgG. Samples were collected
on a three-laser FACSAria (405, 488, and 633 nm) and data
was analyzed using FlowJo software (TreeStar; version 9.7.2
or later).
For detection of NKp46 ligand, neutrophils were treated
with the streptoccal enzyme EndoS, kindly provided by Dr.
Mattias Collin (Lund University, Sweden), at 37◦C for 20min
to digest endogenous IgG bound to the surface of the cells
(45). Cells were subsequently incubated with fusion protein
(10µg/ml) for 30min at 4◦C. Cells were saturated in 20%
goat serum prior to staining with FITC-conjugated Fcγ-specific
goat anti-human IgG (Jackson Immunoresearch Laboratories,
PA, USA).
Detection of NK Cell-Induced Neutrophil
Apoptosis
Freshly isolated neutrophils were stimulated with CL097/GM-
CSF (1µg/ml and 100 U/ml, respectively), or kept at 4◦C
without stimuli, for 1 h. After stimulation the neutrophils were
co-cultured with polyclonal IL-2 activated NK cells at a 10:1
E:T ratio for 3 h at 37◦C in the presence or absence of anti-
HLA-I mAb (clone A6136, IgM), or anti-NKp46 (clone KL247,
IgM). Transmigrated neutrophils collected from skin chamber
exudates or autologous neutrophils isolated from blood were
co-cultured with autologous NK cells, stimulated in IL-12
(1 ng/ml) or IL-15 (10 ng/ml) overnight. Apoptosis and lysis of
neutrophils were detected with FITC-conjugated AnnexinV (BD
Biosciences, CA, USA) and To-Pro-3 (Invitrogen) using flow
cytometry (46).
Statistics
For single pairwise comparisons, paired t-test was used.
For multiple comparisons within a data set, one-way
ANOVA followed by Dunnett’s multiple comparisons test,
was used.
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